Joshua L. Dyme

Senior Clinical Trial Physician
Bristol Myers Squibb

Presentation(s):

• OC 15.1 - PREVAPIX-ALL: Phase 3 Study of the Safety and Efficacy of Apixaban for Thromboprophylaxis versus Standard of Care in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia or Lymphoma (ALL/LL)

  Sunday, July 10, 2022
  10:45 AM – 11:00 AM

• OC 15.2 - The SAXOPHONE Study; A Multi-Center, Multi-National Randomized Trial of Apixaban versus Standard of Care Anticoagulation for Thromboprophylaxis in Children with Congenital or Acquired Heart Disease

  Sunday, July 10, 2022
  11:00 AM – 11:15 AM

• PB0254 - Effects of apixaban versus vitamin K antagonists and low molecular weight heparin in pediatric cardiac patients: exploratory biomarker analysis from SAXOPHONE a multicentre randomized clinical trial

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM